Table II.
Pathology type and adjuvant therapy
| Patient number | Pathology type | Chemotherapy | Radiation therapy | Time from final adjuvant therapy to measurement (mths) |
|---|---|---|---|---|
| 1 | Malignant fibrous histiocytoma | + | + | 121 |
| 2 | Pleomorphic liposarcoma | - | - | |
| 3 | Malignant fibrous histiocytoma | + | - | 85 |
| 4 | Dedifferentiated liposarcoma | - | + | 83 |
| 5 | Liposarcoma | - | - | |
| 6 | Low-grade fibromyxoid sarcoma | - | - | |
| 7 | Synovial sarcoma | - | - | |
| 8 | Inflammatory myofibroblastic sarcoma | - | - | |
| 9 | Myxofibrosarcoma | + | - | 37 |
| 10 | Malignant peripheral nerve sheath tumour | + | + | 98 |
| 11 | Undifferentiated pleomorphic sarcoma | + | + | 20 |
| 12 | Undifferentiated pleomorphic sarcoma | + | - | 16 |
| 13 | Myxofibrosarcoma | - | - | |
| 14 | Myxofibrosarcoma | - | - | |
| 15 | Myxofibrosarcoma | - | - | |
| 16 | Malignant fibrous histiocytoma | - | - | |
| 17 | Dedifferentiated liposarcoma | - | + | 15 |
| 18 | Myxoid liposarcoma | - | - |